<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0E282778-64FD-4EE7-BE17-31904816A25E"><gtr:id>0E282778-64FD-4EE7-BE17-31904816A25E</gtr:id><gtr:firstName>Rennos</gtr:firstName><gtr:surname>Fragkoudis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FI%2F00001699"><gtr:id>55AF0120-DA8D-4F07-A1E8-FAD77930C08F</gtr:id><gtr:title>Targeted inhibition of Rift Valley Fever Virus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/I/00001699</gtr:grantReference><gtr:abstractText>Rift valley fever virus (RVFV), Bunyaviridae, is a zoonotic arbovirus that causes disease in ruminants and humans. Protection is afforded by vaccination however; current vaccines induce complications in livestock. Together with the outbreak potential, the lack of prophylaxis makes RVFV a serious public health concern. Innovative ways to create safe vaccines are needed that will induce lifelong immunity in the animal host and be non-transmissible by arthropod vectors. An upcoming field in antiviral research involves microRNAs (miRNA) which may inhibit viral replication in vitro or restrict cellular tropism for a variety of viruses. 
Within efforts to generate genetically modified RVFV vaccines, miRNA targets that are conserved within Aedes mosquito cell lines will be chosen for targeted inhibition of RVFV. Selection criteria for miRNAs include high copy number in each cell line and insect specificity. Constructs containing selected miRNA targets will be cloned into the SVF4 genome to establish the knockdown efficacy of virus replication in different cell lines. miRNA targets showing greatest efficacy will be cloned into the NSs region of the S-segment of RVFV, allowing for the characterization of recombinant RVFV in various mosquito and vertebrate cell lines and define the host range of these viruses in live mosquitoes.</gtr:abstractText><gtr:fund><gtr:end>2017-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-03-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>898273</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>This new research has not yet achieved an impact. We are using the fundamental knowledge obtained to design new arbovirus vaccines. This has the potential to contribute to human and animal health, and thus food security, in many regions of the world.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>0E7C0156-B07A-4EF5-9D5A-E8179DD4924F</gtr:id><gtr:impactTypes/><gtr:outcomeId>5462004c41dcf3.38025057</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>By high throughput sequencing, we determined the transcriptome and the miRNAs, of the Asian Tiger Mosquito (Aedes albopictus). We then used these to engineer viruses that would be targetted by these miRNAs with the aim of generating viruses unable to replicate in arthropod cells but capable of replicating in mammalian cells. Using Semliki Forest virus and Rift valley fever virus, we showed this to be the case.</gtr:description><gtr:exploitationPathways>This proof of principle research could be exploited to design live attenuated vaccines for arbovirus diseases which are unable to be transmitted by mosquitoes.</gtr:exploitationPathways><gtr:id>5AA5465F-4727-44AB-BD89-357AF94B29E4</gtr:id><gtr:outcomeId>5461ff464b2aa7.71146216</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>67622795-056C-4A7F-AC82-9EC1173E077A</gtr:id><gtr:title>The transient nature of Bunyamwera orthobunyavirus NSs protein expression: effects of increased stability of NSs protein on virus replication.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c8b4760991ae246242c7b4de560d53c"><gtr:id>5c8b4760991ae246242c7b4de560d53c</gtr:id><gtr:otherNames>van Knippenberg I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56cc6f9a1abc67.42636270</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E740ADF-5CDB-413A-8BC2-3D2361723DF4</gtr:id><gtr:title>Tick capillary feeding for the study of proteins involved in tick-pathogen interactions as potential antigens for the control of tick infestation and pathogen infection.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34fdcc941ca8fd028760731382fb1986"><gtr:id>34fdcc941ca8fd028760731382fb1986</gtr:id><gtr:otherNames>Antunes S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>56cc6f97ebb334.92892825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDB3F9FE-F4CE-4373-A280-31125D347A77</gtr:id><gtr:title>Knockdown of piRNA pathway proteins results in enhanced Semliki Forest virus production in mosquito cells.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89354079a660811744cb1a251293992"><gtr:id>b89354079a660811744cb1a251293992</gtr:id><gtr:otherNames>Schnettler E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>546366a34474f5.49110442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A381D2FC-CE09-49A6-BFCE-D58ACF7DAA4F</gtr:id><gtr:title>Antiviral responses of arthropod vectors: an update on recent advances.</gtr:title><gtr:parentPublicationTitle>Virusdisease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/058a9348c45353a3fc4826c35a40b14a"><gtr:id>058a9348c45353a3fc4826c35a40b14a</gtr:id><gtr:otherNames>R?ckert C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2347-3584</gtr:issn><gtr:outcomeId>56cc70d9442ee1.02855847</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/I/00001699</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>